New gel tested to soothe painful rash from cancer drugs

NCT ID NCT06830863

Summary

This study is testing a new topical gel, ATR04-484, to see if it is safe and can help treat a severe, itchy skin rash that is a common side effect of certain cancer medications (EGFR inhibitors). Adult cancer patients with this moderate-to-severe rash will apply the gel or a placebo version daily for 28 days. Researchers will compare the two groups to see if the gel improves the rash, reduces itching and pain, and helps patients feel better.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EGFR INHIBITOR-ASSOCIATED RASH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Genesis Cancer and Blood Institute

    RECRUITING

    Hot Springs, Arkansas, 71913, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Inova Schar Cancer

    RECRUITING

    Fairfax, Virginia, 22031, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • MD Anderson

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • NYU Langone

    RECRUITING

    New York, New York, 10016, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Ohio State University

    RECRUITING

    Gahanna, Ohio, 43230, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Yale University School of Medicine

    RECRUITING

    New Haven, Connecticut, 06510, United States

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.